|
Journal of Histochemistry and Cytochemistry, Vol. 46, 77-84, Copyright © 1998 by The Histochemical Society, Inc.
Expression of Prostaglandin G/H Synthase Type 1, but not Type 2, in Human Ovarian Adenocarcinomas
Monique Doréa,
Lucie C. Côtéa,
Andrew Mitchellc, and
Jean Siroisb
a Département de Pathologie et Microbiologie, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada
b CRRA/Département de Biomédecine Vétérinaire, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada
c Faculté de Médecine Vétérinaire, Université de Montréal, St-Hyacinthe, Québec, Canada and Département de Pathologie, Hôpital Maisonneuve-Rosemont,
Montréal, Québec, Canada\n\n
Correspondence to:
Jean Sirois, Département de Biomédecine Vétérinaire, Université de Montréal, CP 5000, St-Hyacinthe, Québec, Canada J2S 7C6.
Prostaglandin endoperoxide synthase (PGHS) is a key rate-limiting enzyme in prostaglandin biosynthesis. PGHS has recently been shown to be expressed in human colorectal cancers and in experimental cutaneous papillomas and carcinomas. However, PGHS expression has not been investigated in ovarian cancers. The objectives of this study were to determine whether PGHS isoenzymes are expressed in human ovarian cancer and, if so, to identify which isoform is involved (PGHS-1 and/or PGHS-2) and to characterize its cellular localization. Sixteen human ovarian adenocarcinomas were studied by immunohistochemistry using specific antibodies recognizing PGHS-1 or PGHS-2. Results showed that all adenocarcinomas demonstrated the presence of tumor cells expressing PGHS-1 but not PGHS-2. Patterns of staining of tumor cells varied among different types of adenocarcinomas, with cells presenting either a mostly diffuse cytoplasmic immunoreactivity or, alternatively, a staining mainly concentrated around the nucleus. No correlation between the intensity of the immunostaining and the degree of malignancy of tumors could be established (r 5 20.03; p>0.05). Immunoblot analysis with PGHS-1-selective antibodies of cell extracts from adenocarcinomas revealed the presence of a characteristic 72,000 Mr immunoreactive band. Therefore, these results show for the first time that PGHS-1 is expressed in human ovarian adenocarcinomas. (J Histochem Cytochem 46:77-84, 1998)
Key Words:
prostaglandin endoperoxide synthase, cyclo-oxygenase, ovary, adenocarcinomas, prostaglandins

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. M. Robinson-Smith, I. Isaacsohn, C. A. Mercer, M. Zhou, N. Van Rooijen, N. Husseinzadeh, M. M. McFarland-Mancini, and A. F. Drew
Macrophages Mediate Inflammation-Enhanced Metastasis of Ovarian Tumors in Mice
Cancer Res.,
June 15, 2007;
67(12):
5708 - 5716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Weinheimer, B. Jemiolo, C. C. Carroll, M. P. Harber, J. M. Haus, N. A. Burd, J. K. LeMoine, S. W. Trappe, and T. A. Trappe
Resistance exercise and cyclooxygenase (COX) expression in human skeletal muscle: implications for COX-inhibiting drugs and protein synthesis
Am J Physiol Regulatory Integrative Comp Physiol,
June 1, 2007;
292(6):
R2241 - R2248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. N. Jabbour, K. J. Sales, S. C. Boddy, R. A. Anderson, and A. R. W. Williams
A Positive Feedback Loop that Regulates Cyclooxygenase-2 Expression and Prostaglandin F2{alpha} Synthesis via the F-Series-Prostanoid Receptor and Extracellular Signal-Regulated Kinase 1/2 Signaling Pathway
Endocrinology,
November 1, 2005;
146(11):
4657 - 4664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Daikoku, D. Wang, S. Tranguch, J. D. Morrow, S. Orsulic, R. N. DuBois, and S. K. Dey
Cyclooxygenase-1 Is a Potential Target for Prevention and Treatment of Ovarian Epithelial Cancer
Cancer Res.,
May 1, 2005;
65(9):
3735 - 3744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-L. Erkinheimo, H. Lassus, P. Finne, B. P. van Rees, A. Leminen, O. Ylikorkala, C. Haglund, R. Butzow, and A. Ristimaki
Elevated Cyclooxygenase-2 Expression Is Associated with Altered Expression of p53 and SMAD4, Amplification of HER-2/neu, and Poor Outcome in Serous Ovarian Carcinoma
Clin. Cancer Res.,
January 15, 2004;
10(2):
538 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Raju and R. P. Bird
Energy Restriction Reduces the Number of Advanced Aberrant Crypt Foci and Attenuates the Expression of Colonic Transforming Growth Factor {beta} and Cyclooxygenase Isoforms in Zucker Obese (fa/fa) Rats
Cancer Res.,
October 15, 2003;
63(20):
6595 - 6601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ermert, C. Dierkes, and M. Ermert
Immunohistochemical Expression of Cyclooxygenase Isoenzymes and Downstream Enzymes in Human Lung Tumors
Clin. Cancer Res.,
May 1, 2003;
9(5):
1604 - 1610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Gupta, L. V. Tejada, B. J. Tong, S. K. Das, J. D. Morrow, S. K. Dey, and R. N. DuBois
Cyclooxygenase-1 is Overexpressed and Promotes Angiogenic Growth Factor Production in Ovarian Cancer
Cancer Res.,
March 1, 2003;
63(5):
906 - 911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Sales, A. A. Katz, R. P. Millar, and H. N. Jabbour
Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signalling in cervical adenocarcinoma cells
Mol. Hum. Reprod.,
December 1, 2002;
8(12):
1065 - 1070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Nasi and M. Castiglione
Cyclooxygenase-2 (COX-2) a new prognostic and predictive factor for ovarian cancer? Are all the criteria fulfilled?
Ann. Onc.,
August 1, 2002;
13(8):
1169 - 1171.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lajoie, J. Sirois, and M. Dore
Induction of Cyclo-oxygenase-2 Expression in Naturally Occurring Gastric Ulcers
J. Histochem. Cytochem.,
July 1, 2002;
50(7):
923 - 934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Denkert, M. Kobel, S. Pest, I. Koch, S. Berger, M. Schwabe, A. Siegert, A. Reles, B. Klosterhalfen, and S. Hauptmann
Expression of Cyclooxygenase 2 Is an Independent Prognostic Factor in Human Ovarian Carcinoma
Am. J. Pathol.,
March 1, 2002;
160(3):
893 - 903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. P. de Almeida, C. Piche, J. Sirois, and M. Dore
Expression of Cyclo-oxygenase-2 in Naturally Occurring Squamous Cell Carcinomas in Dogs
J. Histochem. Cytochem.,
July 1, 2001;
49(7):
867 - 876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Stockton and B. S. Jacobson
Modulation of Cell-Substrate Adhesion by Arachidonic Acid: Lipoxygenase Regulates Cell Spreading and ERK1/2-inducible Cyclooxygenase Regulates Cell Migration in NIH-3T3 Fibroblasts
Mol. Biol. Cell,
July 1, 2001;
12(7):
1937 - 1956.
[Abstract]
[Full Text]
[PDF]
|
 |
|
The Journal of Histochemistry & Cytochemistry
is owned, published, and licensed by
The Histochemical Society © 1998
|
|
|